Gossamer Bio Inc
GOSS
$10.73-5.81%
End of day · as of Sep 13, 2026, 9:00 PM ET
Mkt cap
$46.99M
EV/Sales
0.19
P/E ratio
N/A
FY2025 Revenue
$48.47M
EPS (TTM)
$-0.66
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-351.49%
Beta
2.15
Div yield
N/A
Sector
Healthcare
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
Latest reported GOSS revenue for 2025-12-31 was $48.5M. Net income was -$170.4M. Revenue was down 57.7% from 2024-12-31 to 2025-12-31. GOSS currently screens at market cap $47.0M.
Use this GOSS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full GOSS income, balance, and cash tables.
Gossamer Bio Inc (GOSS) is a biotechnology company in the Healthcare sector.
Latest cached Gossamer Bio Inc (GOSS) revenue for Dec 31, 2025 was $48.5M. Net income was -$170.4M. Statements: https://lician.com/financials/goss
Gossamer Bio Inc (GOSS) market capitalization is $47.0M on the latest cached snapshot.
Gossamer Bio Inc (GOSS) cached previous close $11.39; day range $10.47 – $12.52; volume 471,920. Session quote: https://lician.com/quote/goss
Gossamer Bio Inc (GOSS) latest cached earnings event is "GOSS earnings" on Aug 18, 2026. Earnings calendar: https://lician.com/earnings
The latest cached GOSS filing is 8-K · Sep 28, 2026. Filings: https://lician.com/sec/goss